Private biotech 2004—the numbers

被引：0

作者：

John Hodgson

机构：

[1] Editor-at-Large for Nature Biotechnology and a director of Critical I Limited,

[2] The Colin Sanders Innovation Centre,undefined

来源：

Nature Biotechnology | 2006年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.

引用

页码：635 / 641

页数：6

共 50 条

[1] Private biotech 2004 - the numbers
Hodgson, J
[J]. NATURE BIOTECHNOLOGY, 2006, 24 (06) : 635 - 641
[2] Biotech by the numbers
Kostel, K
[J]. SCIENTIST, 2004, 18 (11): : 49 - 49
[3] Public biotech: The numbers
Riku Lähteenmäki
Adam Michael
John Hodgson
[J]. Nature Biotechnology, 1998, 16 : 425 - 427
[4] Public biotech:: The numbers
Lähteenmäki, R
Michael, A
Hodgson, J
[J]. NATURE BIOTECHNOLOGY, 1998, 16 (05) : 425 - 427
[5] Biotech's wellspring: the health of private biotech in 2012
Brady Huggett
[J]. Nature Biotechnology, 2013, 31 : 396 - 403
[6] Biotech's wellspring: the health of private biotech in 2012
Huggett, Brady
[J]. NATURE BIOTECHNOLOGY, 2013, 31 (05) : 396 - 403
[7] Biotech's wellspring: the health of private biotech in 2013
Brady Huggett
[J]. Nature Biotechnology, 2014, 32 : 428 - 435
[8] Biotech's wellspring: the health of private biotech in 2013
Huggett, Brady
[J]. NATURE BIOTECHNOLOGY, 2014, 32 (05) : 428 - 435
[9] Public biotech in 2016—the numbers
Chris Morrison
Riku Lähteenmäki
[J]. Nature Biotechnology, 2017, 35 : 623 - 629
[10] Public biotech 2010—the numbers
Brady Huggett
John Hodgson
Riku Lähteenmäki
[J]. Nature Biotechnology, 2011, 29 : 585 - 591

← 1 2 3 4 5 →